Vaccines for Children
Has your child received all the recommended vaccines?
www.First5California.com
Has your child received all the recommended vaccines?
www.First5California.com
Immunization Children
Is this the responsible thing to do as parents? Share your view
www.ResponsibilityProject.com
Is this the responsible thing to do as parents? Share your view
www.ResponsibilityProject.com
Related Business Topics
Company Profiles
Advanced Magnetics, Inc.. The Group's principal activities are to develop and manufacture iron replacement therapeutics and magnetic resonance imaging (MRI) contrast agents. The products of the Group are used in the treatment of chronic anemia a...
Aronex Pharmaceuticals, Inc. is a development stage company and has not yet generated any significant revenues. The company has devoted substantially all of its efforts to reserach and product development. The company identifies and develops med...
AtheroGenics, Inc.. The Group's principal activity is to discover, develop and commercialize drugs for the treatment of chronic inflammatory diseases. These drugs are used in the treatment of atherosclerosis, heart disease, asthma, organ transpl...
Aviron. The Company is a biopharmaceutical company which focuses on prevention of disease through innovative vaccine technology. The vaccine development programs are based on techniques for producing attenuated live virus vaccines and proprietar...
AXYS Pharmaceuticals, Inc.. The principal activities of the Group are the integration of drug discovery technology from gene distribution through clinical development which focuses on small molecule therapeutics and cover a broad range of therap...
Boston Life Sciences, Inc.. The Group's Principal Activity is The Research And Development of Novel Therapeutic And Diagnostic Products to Treat Chronic Debilitating Diseases Such as Cancer And Central Nervous System Disorders. Still in Its Deve...
Celgene Corporation. The Group's principal activity is to discover, develop and market innovative therapies for immune-inflammatory-related diseases through the regulation of cells, genes and proteins associated with diseases. It operates in one...
Chiron Corporation. The Group's principal activity is to develop, manufacture and market human healthcare products. It operates in three segments Biopharmaceuticals, Vaccines and Blood Testing. Biopharmaceuticals segment discovers, develops, man...
Corixa Corporation. The Group's principal activity is to develop innovative immunotherapeutic products designed to affect the immune system and treat debilitating and life-threatening conditions caused by cancer and infectious disease. The produ...
CytRx Corporation. The Group's principal activity is the development and commercialisation of pharmaceutical products. It is involved in the development of novel small molecules based on molecular 'chaperone' co-induction technology, with broad ...
DOR BioPharma, Inc.. The Group's principal activity is to research and develop biodefense vaccines and oral therapeutic products intended for areas of unmet medical need. It maintains two active segments: BioDefense and BioTherapeutics. BioDefen...
First Horizon Pharmaceutical Corporation. The Group's Principal Activity is to Market Brand Name Prescription Drugs. The Group Intends to Develop New Patentable Formulations, Use New Delivery Methods And Seek Regulatory Approval For New Indicati...
Genvec Inc. The Group's principal activities are to develop innovative gene-based therapeutics to treat serious and life-threatening diseases such as cancer, heart disease and diseases of the eye. The Group is also developing cell transplantatio...
Biotechnology company developing novel drug candidates primarily based on glycobiology.
SEE ALSO:
Profile
Ibex Technologies Inc.(ibex). The Group's Principal Activities Are to Develop And Commercialize Biological Biomakers For Diagnosis of Diseases, Monitor Drug Therapy And Develop Drug Treatment. The Group Develops Enzymes For a Variety of Therapeu...
Icos Corporation. The Group's principal activity is to discover and develop breakthrough, proprietary products for the treatment of serious medical diseases. The Group has expertise in both protein-based and small molecule therapeutics. The Grou...
CONTRACT RESEARCH & DEVELOPMENT ACCOUNTED FOR 70% OF 2000 REVENUES & LICENSE FEES, 30%
Immunomedics, Inc.. The Group's principal activity is to develop, manufacture and market monoclonal antibody-based products for the detection and treatment of cancer, autoimmune and other serious diseases. The Group has developed a number of adv...
SEE ALSO:
Profile
Innovata PLC Formerly known as M.L. Laboratories PLC. The Group's principal activity is developing and commercialising pharmaceutical products and technologies. The Group's operation focuses on adhesions, pain, renal failure, inhalation medicine...
DISCOVERS, DEVELOPS AND COMMERCIALIZES NOVEL ANTIMICROBIALS FOR THE TREATMENT OF SERIOUS BACTERIAL, FUNGAL AND VIRAL INFECTIONS
SEE ALSO:
Profile
Migenix Incorporated Formerly Known as Micrologix Biotech Incorporated. The Group's Principal Activities Are to Conduct Research, Develop And to Sell Drugs And Therapeutic Products. The Group's Focus is Toward Anti-Infective Drugs With Four Prod...
SEE ALSO:
Profile
Merck Serono S.A. Formerly known as Serono SA. The Group's principal activities are the research, development, production and marketing of prescription pharmaceuticals. The Group's products are organized into the following therapeutic areas: Rep...
SEE ALSO:
Profile
Siegfried Holding AG. The Group's principal activities are the supply of customised services for the pharmaceutical research sector and the development and marketing of medicinal and herbal teas. The Group operates through the following division...
Titan Pharmaceuticals Inc. The Group's principal activity is to develop proprietary therapeutics for the treatment of central nervous system (CNS) disorders, cancer and cardiovascular disease. The product development programs of the Group focus ...
Collaborative research and development accounted for 91% of 2000 revenues and Licenses, 9%
XOMA Ltd.. The Group's principal activity is to develop and manufacture antibodies and other genetically engineered protein products to treat cancer, immunological and inflammatory disorders and infectious diseases. The Group's products are pres...
Vaccines for Children
Has your child received all the recommended vaccines?
www.First5California.com
Has your child received all the recommended vaccines?
www.First5California.com
Immunization Children
Is this the responsible thing to do as parents? Share your view
www.ResponsibilityProject.com
Is this the responsible thing to do as parents? Share your view
www.ResponsibilityProject.com
